ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
2
views
0
references
Top references
cited by
58
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
6,291
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Resolution of severe ipilimumab-induced hepatitis after antithymocyte globulin therapy.
Author(s):
Christopher Liddle
,
Brian Nankivell
,
Richard Kefford
,
Ramy Ibrahim
,
Katarzyna Chmiel
,
David Fulcher
,
John F Thompson
,
Dan Suan
,
Adrienne C. Bautista
Publication date:
2011-03-20
Journal:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Keywords:
Antibodies, Monoclonal
,
therapeutic use
,
Antilymphocyte Serum
,
adverse effects
,
Drug-Induced Liver Injury
,
drug therapy
,
Humans
,
Lymphatic Metastasis
,
Male
,
Melanoma
,
Middle Aged
,
Platelet Count
,
Survival Rate
,
T-Lymphocytes
,
pathology
,
Treatment Outcome
Read this article at
ScienceOpen
Publisher
PubMed
Further versions
open (via free pdf)
Powered by
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Neuropharmacology and Therapy
Author and article information
Journal
PubMed ID::
21220617
DOI::
10.1200/JCO.2010.32.2206
ScienceOpen disciplines:
Chemistry
Keywords:
Antibodies, Monoclonal
,
therapeutic use
,
Antilymphocyte Serum
,
adverse effects
,
Drug-Induced Liver Injury
,
drug therapy
,
Humans
,
Lymphatic Metastasis
,
Male
,
Melanoma
,
Middle Aged
,
Platelet Count
,
Survival Rate
,
T-Lymphocytes
,
pathology
,
Treatment Outcome
Data availability:
ScienceOpen disciplines:
Chemistry
Keywords:
Antibodies, Monoclonal
,
therapeutic use
,
Antilymphocyte Serum
,
adverse effects
,
Drug-Induced Liver Injury
,
drug therapy
,
Humans
,
Lymphatic Metastasis
,
Male
,
Melanoma
,
Middle Aged
,
Platelet Count
,
Survival Rate
,
T-Lymphocytes
,
pathology
,
Treatment Outcome
Comments
Comment on this article
Sign in to comment
scite_
Similar content
6,291
Retraitement par globuline antithymocyte en induction pour deuxième transplantation rénale : efficacité et tolérance
Authors:
E. Rodriguez Reimundes
,
F Buron
,
C Chauvet
…
Expérience du CHU de Saint-Étienne dans un nouveau traitement du mélanome métastatique : ipilimumab
Authors:
L. Gabriel
,
J. Mordini
,
B Labeille
…
Preliminary interim results of the first-in-human, dose-finding PROCLAIM-CX-072 trial of the PD-L1 Probody therapeutic (Pb-Tx) CX-072 in combination with ipilimumab (ipi) in patients (pts) with advanced solid tumors.
Authors:
Rachel E. Sanborn
,
Catharina Menke
,
Karen Autio
…
See all similar
Cited by
56
Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysis
Authors:
Anne Bertrand
,
Marie Kostine
,
Thomas Barnetche
…
Moving towards personalized treatments of immune-related adverse events
Authors:
Khashayar Esfahani
,
Arielle Elkrief
,
Cassandra M Calabrese
…
Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Authors:
J Haanen
,
M. Obeid
,
L Spain
…
See all cited by